首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.
【2h】

Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.

机译:钙拮抗剂和内分泌状态:口服维拉帕米对垂体-睾丸和垂体-甲状腺功能缺乏影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Calcium ions seem to be essential for the release of many hormones. The calcium antagonist verapamil which is used as an anti-arrhythmic and anti-anginal agent has an inhibitory effect on the release of follicle stimulating hormone (FSH), luteinising hormone (LH), and thyrotrophin stimulating hormone (TSH) when given as an intravenous infusion to normal volunteers. As verapamil is usually given orally we studied pituitary-testicular and pituitary-thyroid function before and after completing a 4-week course of oral verapamil. The oral preparation did not have any significant effect on the endocrine parameters studied.
机译:钙离子似乎对释放许多激素至关重要。静脉使用静脉内给予抗心律失常和抗心绞痛药的钙拮抗剂维拉帕米对卵泡刺激素(FSH),黄体生成素(LH)和促甲状腺激素刺激素(TSH)的释放具有抑制作用输给正常志愿者。由于通常口服维拉帕米,因此我们在完成为期4周的口服维拉帕米疗程之前和之后研究了垂体-睾丸和垂体-甲状腺功能。口服制剂对研究的内分泌参数没有任何显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号